会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS
    • 小分子MALALAL ALDOLASE-TRAP增强剂和GLIDEOSOME抑制剂
    • US20140275088A1
    • 2014-09-18
    • US14353438
    • 2012-10-25
    • NEW YORK UNIVERSITYJOHNS HOPKINS UNIVERSITY
    • Timothy J. CardozoJürgen BoschSondra Maureen Nemetski
    • C07C249/16C07D215/14C07D333/24C07D207/337C07C235/78G06F19/12C07D239/47C07D487/04C07D239/46G06F19/16C12Q1/527C07C243/18C07D271/12
    • C07C249/16C07C235/78C07C243/18C07D207/337C07D215/14C07D239/46C07D239/47C07D239/54C07D271/12C07D277/34C07D333/24C07D487/04C12Q1/527G01N2333/44G01N2333/445G01N2500/04G06F19/12G06F19/16
    • In one aspect, the present invention relates to a method of identifying compounds useful in modifying the activity of Aldolase. The method includes providing a first model comprising Aldolase or residues of the amino acid sequence corresponding to SEQ ID NO: 1 said residues being at amino acid positions selected from the group consisting of 10-13, 26, 27, 29, 30, 31, 32, 33, 37, 39, 40, 41, 43, 44, 47, 48, 51, 52, 60, 63, 66, 79, 84, 85, 92, 93, 103, 106-109, 112-117, 138, 142, 146, 148, 151, 153, 179, 182, 183, 185, 186, 194, 196, 197, 198, 199, 208, 226-228, 231-269, 270, 272, 277-283, 285-289, 294, 295, 297-299, 301-304, 306-310 312, 313, 316, 317, 319, 321, 323, 326, 330, 344, 345, and 347, providing one or more candidate compounds, evaluating contact between the candidate compounds and the first model to determine which of the one or more candidate compounds have an ability to bind to and/or fit in the first model, and identifying compounds which, based on said evaluating, have the ability to bind to and/or fit in the first model as compounds potentially useful for modifying the activity of Aldolase. The present invention also discloses compounds and compositions which modify the activity of Aldolase, or a complex between Aldolase and TRAP. Methods of treating or preventing malaria, or an infection by apicomplexan organisms are also disclosed.
    • 一方面,本发明涉及鉴定可用于改变醛缩酶活性的化合物的方法。 该方法包括提供包含Aldolase或对应于SEQ ID NO:1的氨基酸序列的残基的第一模型,所述残基位于选自下组的氨基酸位置:10-13,26,27,29,30,31, 32,33,37,39,40,41,43,44,47,48,51,52,60,63,66,79,84,85,92,93,103,106-109,112-117, 138,142,146,148,151,153,179,182,183,185,186,194,196,197,198,199,208,226-228,231-269,270,272,277-283, 285-289,294,295,297-299,301-304,306-310 312,313,316,317,319,321,232,326,330,344,345和347,提供一种或多种候选化合物 评估候选化合物与第一模型之间的接触以确定一种或多种候选化合物中的哪一种具有结合和/或适合于第一模型的能力,以及鉴定化合物,其基于所述评估具有 与第一模型结合和/或适合作为可能用于改变醛缩酶活性的化合物。 本发明还公开了改变Aldolase活性的化合物和组合物,或Aldolase和TRAP之间的复合物。 还公开了治疗或预防疟疾或由复合物有机体感染的方法。
    • 83. 发明授权
    • Microwave induced single step green synthesis of some novel 2-aryl aldehydes and their analogues
    • 微波诱导单步绿色合成一些新型2-芳基醛及其类似物
    • US08779200B2
    • 2014-07-15
    • US13203100
    • 2010-02-25
    • Arun Kumar SinhaAbhishek SharmaRakesh KumarNaina Sharma
    • Arun Kumar SinhaAbhishek SharmaRakesh KumarNaina Sharma
    • C07C241/00C07C47/00
    • C07C45/28C07C45/30C07C249/16C07C311/49C07D317/54C07C47/228C07C47/24C07C47/23C07C47/277
    • The present invention provides a process for the preparation of some novel 2-aryl and 2,2-diaryl aldehydes and analogues which are privileged intermediates for commercially important nonsteroidal anti-inflammatory drugs including naproxen, flurbiprofen and potent anticancer drug candidates, including phenstatin through a unique single step synthetic methodology utilizing easily available substrates in the form of aryl alkenes as well as environmentally benign aqueous reaction conditions in the form of solvents such as mixtures of water and DMSO or Dioxane and reagents N-bromosuccinimide, N-iodosuccinimide, N-cholorosuccinimide and phase transfer catalyst such as cetyltrimethyl ammonium bromide, N-hexyl ammonium chloride for a reaction time varying from 1 min-30 min, depending upon microwave or conventional heating, without using expensive transition metal catalysts or lewis acids/bases with yield varying from 35-55%, depending upon the solvent and substrate used. The developed method provides a clean and convenient alternative to access a diverse range of medicinally important 2-aryl and 2,2-diaryl aldehyde based scaffolds in lieu of the conventional multistep protocols employing expensive and hazardous transition metal catalysts and lewis acids/bases.
    • 本发明提供了一种制备一些新的2-芳基和2,2-二芳基醛和类似物的方法,其是用于商业上重要的非甾族抗炎药物的特权中间体,包括萘普生,氟比洛芬和有效的抗癌药物候选物,包括通过 使用易于获得的芳基烯烃底物的独特的单步合成方法以及溶剂形式的环境友好的水性反应条件,例如水和DMSO或二恶烷的混合物以及试剂N-溴琥珀酰亚胺,N-碘代琥珀酰亚胺,N-氯代氯代琥珀酰亚胺 和相转移催化剂如十六烷基三甲基溴化铵,N-己基氯化铵,反应时间为1分钟-30分钟,取决于微波或常规加热,不使用昂贵的过渡金属催化剂或路易斯酸/碱,产率从35 -55%,这取决于所用的溶剂和底物。 开发的方法提供了一种干净和方便的替代方案,以便获得各种各样的药物重要的2-芳基和2,2-二芳基醛基支架,代替常规的多步骤方案,其采用昂贵且危险的过渡金属催化剂和路易斯酸/碱。
    • 84. 发明申请
    • MICROWAVE INDUCED SINGLE STEP GREEN SYNTHESIS OF SOME NOVEL 2-ARYL ALDEHYDES AND THEIR ANALOGUES
    • 微波诱导的单步绿色合成一些新型二芳基醛及其类似物
    • US20120041234A1
    • 2012-02-16
    • US13203100
    • 2010-02-25
    • Arun Kumar SinhaAbhishek SharmaRakesh KumarNaina Sharma
    • Arun Kumar SinhaAbhishek SharmaRakesh KumarNaina Sharma
    • C07C251/80C07C45/00B01J19/12C07C47/27
    • C07C45/28C07C45/30C07C249/16C07C311/49C07D317/54C07C47/228C07C47/24C07C47/23C07C47/277
    • The present invention provides a process for the preparation of some novel 2-aryl and 2,2-diaryl aldehydes and analogues which are privileged intermediates for commercially important nonsteroidal anti-inflammatory drugs including naproxen, flurbiprofen and potent anticancer drug candidates, including phenstatin through a unique single step synthetic methodology utilizing easily available substrates in the form of aryl alkenes as well as environmentally benign aqueous reaction conditions in the form of solvents such as mixtures of water and DMSO or Dioxane and reagents N-bromosuccinimide, N-iodosuccinimide, N-cholorosuccinimide and phase transfer catalyst such as cetyltrimethyl ammonium bromide, N-hexyl ammonium chloride for a reaction time varying from 1 min-30 min, depending upon microwave or conventional heating, without using expensive transition metal catalysts or lewis acids/bases with yield varying from 35-55%, depending upon the solvent and substrate used. The developed method provides a clean and convenient alternative to access a diverse range of medicinally important 2-aryl and 2,2-diaryl aldehyde based scaffolds in lieu of the conventional multistep protocols employing expensive and hazardous transition metal catalysts and lewis acids/bases.
    • 本发明提供了一种制备一些新的2-芳基和2,2-二芳基醛和类似物的方法,其是用于商业上重要的非甾族抗炎药物的特权中间体,包括萘普生,氟比洛芬和有效的抗癌药物候选物,包括通过 使用易于获得的芳基烯烃底物的独特的单步合成方法以及溶剂形式的环境友好的水性反应条件,例如水和DMSO或二恶烷的混合物以及试剂N-溴琥珀酰亚胺,N-碘代琥珀酰亚胺,N-氯代氯代琥珀酰亚胺 和相转移催化剂如十六烷基三甲基溴化铵,N-己基氯化铵,反应时间为1分钟-30分钟,取决于微波或常规加热,不使用昂贵的过渡金属催化剂或路易斯酸/碱,产率从35 -55%,这取决于所用的溶剂和底物。 开发的方法提供了一种干净和方便的替代方案,以便获得各种各样的药物重要的2-芳基和2,2-二芳基醛基支架,代替常规的多步骤方案,其采用昂贵且危险的过渡金属催化剂和路易斯酸/碱。